Susan Molineaux is at it again: Weeks after biotech closes, she lands as CEO of Para Therapeutics

The CEO scored big with the multiple myeloma drug Kyprolis, then fizzled with Calithera. Her new company is taking another approach to cancer.

Source: bizjournals.com Health Care:Biotechnology headlines - May 10, 2023 Category: Biotechnology Authors: Ron Leuty Source Type: news